Prasad to oversee new priority voucher program

Companies may now apply to receive one of up to five new FDA priority review vouchers designed to streamline reviews of innovative drugs under a pilot program announced in June. The agency will award both product-specific and “undesignated” vouchers that companies can use for products they select. 

Additional information regarding FDA Commissioner’s National Priority Voucher (CNPV) program released Tuesday offers a few more details from the June announcement about how the program will work but falls short of spelling out precisely how companies or their products can qualify. ...